http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

Similarly, De Cos Milas et al. [6] described their clinical experience with paliperidone in adolescents. They presented 3 males and 2 females, age between 15 and 17 years. Diagnoses were autism, borderline personality disorder, schizotypal personality disorder, personality disorder not otherwise specified, and schizophrenia. Prescribed dose was 3–9 mg/day, and actual mean time of treatment duration is 5.8 months. In 4 cases, paliperidone was initiated as a change from other antipsychotic. There were no adverse effects that required discontinuation and in all cases symptoms improved.

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0001087 MONDO_0001087

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/DRUGBANK:DB01267 DRUGBANK:DB01267

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RAHodixuno...#context context

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/31096228 pubmed.ncbi.nlm.nih.gov/31096228

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-08-24T16:13:47.586Z

http://purl.org/np/RAHodixuno... RAHodixuno

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-08-24T16:13:47.586Z